# PumaRx Registry Trial

> **NCT06805461** · — · RECRUITING · sponsor: **RenovoRx** · enrollment: 1000 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DEVICE:** RenovoCath®

## Key facts

- **NCT ID:** NCT06805461
- **Lead sponsor:** RenovoRx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2029-09-03
- **Final completion:** 2029-09-03
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06805461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06805461, "PumaRx Registry Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06805461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*